Xinqi Wu

Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Donald P. Lawrence, Cecilia Lezcano et al. · Cancer Immunology Research · 2014 · 604 citations · Full text

Pharmacy, Immunology, Pharmacology +16

Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade

Jun Zhou, Kathleen M. Mahoney, Anita Giobbie‐Hurder et al. · Cancer Immunology Research · 2017 · 362 citations · Full text

Life Sciences, Immunology, Oncology +17

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)

Andrea Dunaif, Xinqi Wu, Anna Lee et al. · American Journal of Physiology-Endocrinology and Metabolism · 2001 · 334 citations

Medicine, Endocrinology, Physiology +17

Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy

Xinqi Wu, Anita Giobbie‐Hurder, Xiaoyun Liao et al. · Cancer Immunology Research · 2016 · 166 citations · Full text

Life Sciences, Immunology, Oncology +17

Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab

Jianda Yuan, Jun Zhou, Zhiwan Dong et al. · Cancer Immunology Research · 2014 · 140 citations · Full text

Medicine, Clinical Sciences, Oncology +17